Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FM8HY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,927
Award facts
- Contract value 100% obligated
- $13,926.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,926.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for XOLAIR 150 mg/1.2 ml powder vials. This contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge facility with an ultimate completion date of October 7, 2025. The company is a critical supplier within the federal pharmaceutical supply chain, supporting Department of Defense healthcare facilities nationwide with prescription medications and biologics.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, and specialty biologics to meet medical supply needs across military health facilities worldwide. The company has demonstrated consistent success in federal pharmaceutical procurement, leveraging its woman-owned small business status to compete effectively for delivery orders covering diverse product categories from oncology treatments to vaccines and medical consumables.
Quick answers
Who was awarded contract SPE2DB25FM8HY?
SPE2DB25FM8HY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FM8HY worth?
The government has obligated $13,927 on SPE2DB25FM8HY.
Is contract SPE2DB25FM8HY an order under another contract?
Yes. SPE2DB25FM8HY is a delivery order under SPE2DB22D9151, an indefinite delivery contract.
Was contract SPE2DB25FM8HY competed?
The extent of competition for SPE2DB25FM8HY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award